Research Area 2: Generic technology platforms for producing novel and/or improved vaccines
Brucella melitensis infection is an important zoonotic infection for animals and humans at the a lot of country. In the field condition, after vaccination , differentiation of vaccine or field strain's antibodies is not possible by standart serological tests. For these reason, a marker vaccine may be useful for brusellosis eradication plans.
University of Selçuk, Faculty of Veterinary Medicine Department of Microbiology (Immunology and Epidemiology) is working on vaccine develoment of animal infectious diesases and diagnosis. There is an Vaccine R&D Center of University of Selçuk.
We are working with VETAL Animal Health Vaccine Company (www.vetal.com.tr) (Adıyaman-Turkey) since 2001.